Free Trial

Akebia Therapeutics (AKBA) Insider Trading & Ownership

→ Biden replacement revealed? (From Paradigm Press) (Ad)
Free akba Stock Alerts
$1.32
-0.06 (-4.01%)
(As of 10:15 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Akebia Therapeutics (NASDAQ:AKBA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.84%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$562,184.43
Get AKBA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Akebia Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AKBA Insider Buying and Selling by Quarter

Ad Insider Financial
Thousands of investors use this no cost solution | Do you?
In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.
Simply tap here now to subscribe and start getting "Insider Financial Advantage"

Akebia Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/29/2024John P ButlerCEOSell46,570$1.58$73,580.60  
2/29/2024Michel DahanCOOSell8,661$1.58$13,684.38  
2/29/2024Nicole R HadasSVPSell5,974$1.58$9,438.92  
2/27/2024John P ButlerCEOSell37,733$1.52$57,354.16  
2/27/2024Michel DahanCOOSell10,744$1.52$16,330.88  
2/27/2024Nicole R HadasSVPSell7,411$1.52$11,264.72  
2/1/2024John P ButlerCEOSell46,489$1.68$78,101.52  
2/1/2024Steven Keith BurkeSVPSell24,311$1.68$40,842.48  
5/25/2023Michel DahanCOOSell95,478$1.22$116,483.16  
5/25/2023Nicole R HadasSVPSell63,186$1.22$77,086.92  
5/16/2023Steven Keith BurkeSVPSell63,567$1.07$68,016.69  
(Data available from 1/1/2013 forward)

AKBA Insider Trading Activity - Frequently Asked Questions

Who is on Akebia Therapeutics's Insider Roster?

The list of insiders at Akebia Therapeutics includes David A Spellman, John P Butler, Michel Dahan, Nicole R Hadas, Steven C Gilman, Steven Keith Burke, and Violetta Cotreau. Learn more on insiders at AKBA.

What percentage of Akebia Therapeutics stock is owned by insiders?

3.84% of Akebia Therapeutics stock is owned by insiders. Learn more on AKBA's insider holdings.

Which Akebia Therapeutics insiders have been selling company stock?

The following insiders have sold AKBA shares in the last 24 months: David A Spellman ($6,344.80), John P Butler ($289,880.12), Michel Dahan ($164,460.98), Nicole R Hadas ($109,260.48), Steven C Gilman ($1,644.12), and Steven Keith Burke ($108,859.17).

How much insider selling is happening at Akebia Therapeutics?

Insiders have sold a total of 547,215 Akebia Therapeutics shares in the last 24 months for a total of $680,449.67 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:AKBA) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
The #1 Crypto for 2024
InvestorPlace